Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The First-line Combined Chemotherapy for Advanced Gastric Cancer: A Prospective Observational Clinical Study

NCT02583659 is registered in ClinicalTrials.gov with Huazhong University of Science and Technology as lead sponsor.

NCT NCT02583659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02583659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The First-line Combined Chemotherapy for Advanced Gastric Cancer: A Prospective Observational Clinical Study
Lead sponsor
Huazhong University of Science and Technology
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2013
Completion date
January 31, 2018
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer